Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease.
about
Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney diseaseSteviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradationIdentification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plantsPioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.Stimulation of Airway and Intestinal Mucosal Secretion by Natural Coumarin CFTR ActivatorsBenzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATPMolecular modelling and molecular dynamics of CFTR.Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms.Functional architecture of the CFTR chloride channel.Regulation of conductance by the number of fixed positive charges in the intracellular vestibule of the CFTR chloride channel pore.Changes in accessibility of cytoplasmic substances to the pore associated with activation of the cystic fibrosis transmembrane conductance regulator chloride channel.Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channelDehydrocostuslactone, a sesquiterpene lactone activates wild-type and ΔF508 mutant CFTR chloride channel.Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins.Shank2 mutant mice display a hypersecretory response to cholera toxin.Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth
P2860
Q27011660-EF0E9E0C-5685-48F5-A705-FD1C566FB3A7Q28487901-E5549481-395C-439D-AD80-840A392370DCQ28537590-0FD5E3C8-E894-493E-A726-4AC0A8C2AC20Q34260759-EF9FBE88-9F6D-47DC-AA89-E717396DCF3EQ34408604-1DBC6BCD-59B6-480B-8526-88E1D9B7021CQ35233627-7CDD9AFE-A50F-4073-8145-0B13928F4E6CQ36077753-B41E0AF7-F184-4BD7-B455-1CABDE877CAEQ36158194-E3E82DAE-94B0-4750-82A7-3D66EA10E382Q37234590-1B5C5CF5-2DA1-41EA-8338-0359B2FBFA8FQ38171539-F82FE67C-D2C0-4182-86C6-25BBC39066E5Q39289067-E5F7070E-C489-4B71-AED1-13D10DFBEE69Q39673058-EF95C8D0-2129-4D4A-932C-3E31EFD0370EQ42622816-3D20DD0A-BF1A-4F11-B982-4B0F9FF375BBQ42636913-6C47136B-A66F-4576-9A2C-6931C88D2BB0Q44112526-599686F3-A0D9-4490-888B-E9BC5856C807Q51313072-8752699D-A4E7-4EFD-94A0-F0F789E6659BQ52647032-10BDFF36-B339-4970-BBBA-2D871C5AD2E9Q57762189-B3844286-90AF-49B1-8668-0C862A43BB8C
P2860
Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic potential of cysti ...... in polycystic kidney disease.
@en
Therapeutic potential of cystic fibrosis transmembrane conductance regulator
@nl
type
label
Therapeutic potential of cysti ...... in polycystic kidney disease.
@en
Therapeutic potential of cystic fibrosis transmembrane conductance regulator
@nl
prefLabel
Therapeutic potential of cysti ...... in polycystic kidney disease.
@en
Therapeutic potential of cystic fibrosis transmembrane conductance regulator
@nl
P1433
P1476
Therapeutic potential of cysti ...... in polycystic kidney disease.
@en
P2093
David N Sheppard
P304
P356
10.2165/11313570-000000000-00000
P577
2009-01-01T00:00:00Z
P6179
1013664826